161 related articles for article (PubMed ID: 33562748)
1. Discovery of a Small Molecule Inhibitor of Human Adenovirus Capable of Preventing Escape from the Endosome.
Xu J; Berastegui-Cabrera J; Carretero-Ledesma M; Chen H; Xue Y; Wold EA; Pachón J; Zhou J; Sánchez-Céspedes J
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33562748
[TBL] [Abstract][Full Text] [Related]
2. Structure-Activity Relationship Studies on Diversified Salicylamide Derivatives as Potent Inhibitors of Human Adenovirus Infection.
Xu J; Berastegui-Cabrera J; Chen H; Pachón J; Zhou J; Sánchez-Céspedes J
J Med Chem; 2020 Mar; 63(6):3142-3160. PubMed ID: 32045239
[TBL] [Abstract][Full Text] [Related]
3. Discovery of Novel Substituted
Xu J; Berastegui-Cabrera J; Ye N; Carretero-Ledesma M; Pachón-Díaz J; Chen H; Pachón-Ibáñez ME; Sánchez-Céspedes J; Zhou J
J Med Chem; 2020 Nov; 63(21):12830-12852. PubMed ID: 33112138
[TBL] [Abstract][Full Text] [Related]
4. Niclosamide is a proton carrier and targets acidic endosomes with broad antiviral effects.
Jurgeit A; McDowell R; Moese S; Meldrum E; Schwendener R; Greber UF
PLoS Pathog; 2012; 8(10):e1002976. PubMed ID: 23133371
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of Human Adenovirus Replication by the Importin α/β1 Nuclear Import Inhibitor Ivermectin.
King CR; Tessier TM; Dodge MJ; Weinberg JB; Mymryk JS
J Virol; 2020 Aug; 94(18):. PubMed ID: 32641484
[TBL] [Abstract][Full Text] [Related]
6. Retinoic acid receptor β, a potential therapeutic target in the inhibition of adenovirus replication.
Wang X; Zhang Q; Zhou Z; Liu M; Chen Y; Li J; Xu L; Guo J; Li Q; Yang J; Wang S
Antiviral Res; 2018 Apr; 152():84-93. PubMed ID: 29421320
[TBL] [Abstract][Full Text] [Related]
7. Broad-spectrum antiviral activity of the deubiquitinase inhibitor HBX against human adenoviruses.
Kosulin K; Lam E; Heim A; Dobner T; Rodríguez E
Antivir Ther; 2018; 23(6):475-483. PubMed ID: 29557344
[TBL] [Abstract][Full Text] [Related]
8. Histone Deacetylase Inhibitor Suberoylanilide Hydroxamic Acid Suppresses Human Adenovirus Gene Expression and Replication.
Saha B; Parks RJ
J Virol; 2019 Jun; 93(12):. PubMed ID: 30944181
[TBL] [Abstract][Full Text] [Related]
9. A high-content image-based drug screen of clinical compounds against cell transmission of adenovirus.
Georgi F; Kuttler F; Murer L; Andriasyan V; Witte R; Yakimovich A; Turcatti G; Greber UF
Sci Data; 2020 Aug; 7(1):265. PubMed ID: 32788590
[TBL] [Abstract][Full Text] [Related]
10. LINCS dataset-based repositioning of rosiglitazone as a potential anti-human adenovirus drug.
Wang X; He S; Zhou Z; Bo X; Qi D; Fu X; Wang Z; Yang J; Wang S
Antiviral Res; 2020 Jul; 179():104789. PubMed ID: 32353383
[TBL] [Abstract][Full Text] [Related]
11. HAdV-C6 Is a More Relevant Challenge Virus than HAdV-C5 for Testing Antiviral Drugs with the Immunosuppressed Syrian Hamster Model.
Toth K; Spencer JF; Ying B; Tollefson AE; Wold WSM
Viruses; 2017 Jun; 9(6):. PubMed ID: 28608847
[TBL] [Abstract][Full Text] [Related]
12. Emerging antiviral therapeutics for human adenovirus infection: Recent developments and novel strategies.
Dodge MJ; MacNeil KM; Tessier TM; Weinberg JB; Mymryk JS
Antiviral Res; 2021 Apr; 188():105034. PubMed ID: 33577808
[TBL] [Abstract][Full Text] [Related]
13. Antiviral activities of niclosamide and nitazoxanide against chikungunya virus entry and transmission.
Wang YM; Lu JW; Lin CC; Chin YF; Wu TY; Lin LI; Lai ZZ; Kuo SC; Ho YJ
Antiviral Res; 2016 Nov; 135():81-90. PubMed ID: 27742486
[TBL] [Abstract][Full Text] [Related]
14. Comparative Study on the Antivirus Activity of Shuang-Huang-Lian Injectable Powder and Its Bioactive Compound Mixture against Human Adenovirus III In Vitro.
Ma Q; Liang D; Song S; Yu Q; Shi C; Xing X; Luo JB
Viruses; 2017 Apr; 9(4):. PubMed ID: 28417913
[TBL] [Abstract][Full Text] [Related]
15. Development of a novel screening platform for the identification of small molecule inhibitors of human adenovirus.
Saha B; Varette O; Stanford WL; Diallo JS; Parks RJ
Virology; 2019 Dec; 538():24-34. PubMed ID: 31561058
[TBL] [Abstract][Full Text] [Related]
16. Discovery of highly potent small molecule Hepatitis C Virus entry inhibitors.
Mittapalli GK; Jackson A; Zhao F; Lee H; Chow S; McKelvy J; Wong-Staal F; Macdonald JE
Bioorg Med Chem Lett; 2011 Nov; 21(22):6852-5. PubMed ID: 21978675
[TBL] [Abstract][Full Text] [Related]
17. Identification and Characterization of a Novel Broad-Spectrum Virus Entry Inhibitor.
Chou YY; Cuevas C; Carocci M; Stubbs SH; Ma M; Cureton DK; Chao L; Evesson F; He K; Yang PL; Whelan SP; Ross SR; Kirchhausen T; Gaudin R
J Virol; 2016 May; 90(9):4494-4510. PubMed ID: 26912630
[TBL] [Abstract][Full Text] [Related]
18. Sialic Acid-Containing Glycans as Cellular Receptors for Ocular Human Adenoviruses: Implications for Tropism and Treatment.
Chandra N; Frängsmyr L; Imhof S; Caraballo R; Elofsson M; Arnberg N
Viruses; 2019 Apr; 11(5):. PubMed ID: 31035532
[TBL] [Abstract][Full Text] [Related]
19. Neutralization of Acidic Intracellular Vesicles by Niclosamide Inhibits Multiple Steps of the Dengue Virus Life Cycle In Vitro.
Jung E; Nam S; Oh H; Jun S; Ro HJ; Kim B; Kim M; Go YY
Sci Rep; 2019 Jun; 9(1):8682. PubMed ID: 31213630
[TBL] [Abstract][Full Text] [Related]
20. Indirubin-3'-monoxime exhibits potent antiviral and anti-inflammatory effects against human adenoviruses in vitro and in vivo.
Wang J; Yang C; Liang Z; Sun J; Zhang M; Qiu S; Du X; He X; Pang X; Ma X; Xie M; Han X; Fan R; Zhou E; Yu H; She D; Song H; Wang J
Biomed Pharmacother; 2024 May; 174():116558. PubMed ID: 38603887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
